Interruption of dendritic cell-mediated TIM-4 signaling induces regulatory T cells and promotes skin allograft survival.
Interruption of dendritic cell-mediated TIM-4 signaling induces regulatory T cells and promotes skin allograft survival.
复制标题
DOI:
10.4049/jimmunol.1300992
复制
发表时间:
2013-10-15
期刊:
影响因子:
--
通讯作者:
Najafian N
中科院分区:
文献类型:
--
作者:
Yeung MY;McGrath MM;Nakayama M;Shimizu T;Boenisch O;Magee CN;Abdoli R;Akiba H;Ueno T;Turka LA;Najafian N
Dendritic cells (DCs) are the central architects of the immune response, inducing inflammatory or tolerogenic immunity, dependent upon their activation status. As such, DCs are highly attractive therapeutic targets and may hold the potential to control detrimental immune responses. TIM-4, expressed on antigen presenting cells, has complex functions in vivo, acting both as a costimulatory molecule and a phosphatidylserine (PS) receptor. The effect of TIM-4 costimulation on T cell activation remains unclear. Here, we demonstrate that antibody blockade of DC-expressed TIM-4 leads to increased induction of iTregs from naïve CD4+ T cells, both in vitro and in vivo. iTreg induction occurs through suppression of IL-4/STAT6/Gata3 induced Th2 differentiation. In addition, blockade of TIM-4 on previously activated DCs still leads to increased iTreg induction. iTregs induced under TIM-4 blockade have equivalent potency to control and upon adoptive transfer, significantly prolong skin allograft survival in vivo. In RAG−/− recipients of skin allografts adoptively transferred with CD4+ T cells, we show that TIM-4 blockade in vivo is associated with a three-fold prolongation in allograft survival. Furthermore, in this mouse model of skin transplantation, increased induction of allospecific iTregs and a reduction in T effector responses were observed, with decreased Th1 and Th2 responses. This enhanced allograft survival and pro-tolerogenic skewing of the alloresponse is critically dependent upon conversion of naïve CD4+ to Tregs in vivo. Collectively, these studies identify blockade of DC-expressed TIM-4 as a novel strategy which holds the capacity to induce regulatory immunity in vivo.
登录
查看更多内容
DOI:
10.1084/jem.20082394
发表时间:
2009-03-16
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Ohnmacht C;Pullner A;King SB;Drexler I;Meier S;Brocker T;Voehringer D
通讯作者:
Voehringer D
影响因子:
32.4
作者:
Haribhai D;Williams JB;Jia S;Nickerson D;Schmitt EG;Edwards B;Ziegelbauer J;Yassai M;Li SH;Relland LM;Wise PM;Chen A;Zheng YQ;Simpson PM;Gorski J;Salzman NH;Hessner MJ;Chatila TA;Williams CB
通讯作者:
Williams CB
DOI:
10.1073/pnas.0910359107
发表时间:
2010-05-11
影响因子:
11.1
作者:
Rodriguez-Manzanet, Roselynn;Sanjuan, Miguel A.;Kuchroo, Vijay K.
通讯作者:
Kuchroo, Vijay K.
影响因子:
4.4
作者:
Faust, Susan M.;Lu, Guanyi;Marini, Bernard L.;Zou, Weiping;Gordon, David;Iwakura, Yoichiro;Laouar, Yasmina;Bishop, D. Keith
通讯作者:
Bishop, D. Keith
影响因子:
9.8
作者:
Mantel PY;Kuipers H;Boyman O;Rhyner C;Ouaked N;Rückert B;Karagiannidis C;Lambrecht BN;Hendriks RW;Crameri R;Akdis CA;Blaser K;Schmidt-Weber CB
通讯作者:
Schmidt-Weber CB